We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

OncoVista Licenses Phase II Clinical-Stage Drug from OSI Pharmaceuticals

News   Dec 04, 2007

 
OncoVista Licenses Phase II Clinical-Stage Drug from OSI Pharmaceuticals
 
 
Advertisement
 

RELATED ARTICLES

Experts Respond to Reported Death of COVID-19 Vaccine Trial Participant

News

News has emerged from Brazil that a participant of the Phase III clinical trial investigating the COVID-19 vaccine, ChAdOX1, has died.

READ MORE

Gut Bacteria May Be Responsible for Adverse Effect of Parkinson's Drug

News

Bacteria in the small intestine can deaminate levodopa, the main drug that is used to treat Parkinson's disease.

READ MORE

Synthesizing Bacteria-Killing Molecules From Wasp Venom

News

A team of researchers has engineered powerful new antimicrobial molecules from toxic proteins originally found in wasp venom.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE